- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07260149
Cuidados Coordenados para Problemas de Álcool (CCAP)
Cuidados Coordenados para Problemas de Álcool (CCAP): um Ensaio Controlado Randomizado de Goa, Índia
Parallel group individually randomised controlled trial (RCT) with stratified (by severity of drinking problem) randomisation into intervention and control arms. Aim is to test the effectiveness and cost-effectiveness of Coordinated Care for Alcohol Problems (CCAP) for the whole spectrum of drinking problems in primary care in Goa, India. Primary outcome is the drinking outcome of percentage days abstinent (PDA) at three months post randomisation. Secondary outcomes include drinking outcomes (PDA at six- and 12- months post-randomisation; percentage days heavy drinking (PDHD), intensity of drinking and remission) and drinking related outcomes (e.g., injuries, violence) at three-, six- and 12- months post- randomisation. Participants will include consenting adult (>18 years) men with drinking problems attending Primary Healthcare Centres (PHCs) and Community Healthcare Centres (CHCs) in Goa and have drinking problems defined as scoring >8 on the Alcohol Use Disorder Identification Test (AUDIT). CCAP is a multi-component evidence-informed complex intervention package for coordinating treatment for all levels of problem drinking (hazardous, harmful, dependent). For hazardous drinking, it includes Mobile based Brief Intervention Treatment (M-BIT), which is a mobile-messaging brief intervention delivered via WhatsApp over eight weeks using multimedia content including contextually relevant messages, images and videos. For harmful drinking, it includes Counselling for Alcohol Problems Plus (CAP+) which is Counselling for Alcohol Problems (CAP), an evidence-based brief psychological treatment, integrated with strategies to enhance treatment engagement (entry into and completion). For dependent drinking, it includes Community Orientated Treatment for Alcohol Dependence (CONTAD) which is supervised home-detoxification over a week followed by a psychological treatment to prevent relapse, both integrated with treatment engagement strategies. CAP+ and CONTAD will be delivered in the community by non-specialist health workers (NSHW).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Abhijit Nadkarni
- Número de telefone: +91 7887872345
- E-mail: abhijit.nadkarni@lshtm.ac.uk
Estude backup de contato
- Nome: Urvita Bhatia
- Número de telefone: +91 7887872345
- E-mail: urvita.bhatia@lshtm.ac.uk
Locais de estudo
-
-
-
Goa, Índia
- Recrutamento
- Sangath
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
-
Scoring positive for problem drinking (≥ 8 on the AUDIT)
-
Have been residing in Goa for more than 12 continuous preceding months as an indicator of stability of residence which would be required both for treatment delivery and completion of outcome evaluation.
-
Language:
- For hazardous drinking (AUDIT score of 8-15), patients must be able to understand at least one of the local vernacular languages (Hindi or Konkani) or English. Patients must be able to read at least one of the local vernacular languages (Hindi or Marathi) or English.
- For harmful and dependent drinking (AUDIT score of >15), patients must be able to understand and speak any of the local vernacular languages (Konkani, Marathi, Hindi) or English.
-
For hazardous drinking, patients must also have access to a personal smartphone with WhatsApp.
-
For dependent drinking (AUDIT score of >19), patients must consent for home visits and must also be eligible for home detoxification as per structured detoxification protocol.
Exclusion Criteria:
- For hazardous drinking, patients with significant visual or hearing impairment will be ineligible due to the audio-visual nature of the intervention.
- For harmful and dependent drinking, patients with significant speech, hearing, or language impairment (as evident during screening) will be excluded as the intervention is primarily a 'talking treatment'.
- For patients who present to the PHC/CHC needing urgent medical attention (emergency treatment or in-patient admission), screening will be deferred until their condition is stable.
- Those who are alcohol dependent and do not meet the eligibility criteria for home detoxification as per protocol.
- Those who are alcohol dependent but are currently not drinking. As AUDIT covers a period of 12 months, it will also detect those who meet the criteria for alcohol dependence over the past 12 months but are currently abstinent (hence not eligible for detoxification).
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: CCAP
Hazardous drinking: M-BIT is an eight-week digital intervention delivered over WhatsApp. Harmful drinking: CAP is a manualised brief psychological treatment for harmful drinking. CAP+ will include treatment engagement strategies integrated into CAP. Dependent drinking: CONTAD is a manualised treatment comprising of 5-7 days of supervised home detoxification followed by relapse prevention counselling for dependent drinking. Participants with harmful and dependent drinking level will be offered referral to the public District Hospitals or the state Psychiatric Hospital for assessment of eligibility for anti-craving medicines if available and to be prescribed and dispensed as per their Standard Operating Procedures. |
Hazardous drinking: The content of the intervention includes seven themes: health education, alcohol reduction, drinking and risk management, drinking alternatives, situational content, urge management, and relapse prevention. Participants will receive texts and video-based messages building their awareness about drinking and associated harms. Harmful drinking: CAP has three phases which are delivered in one to four sessions over six to eight weeks by NSHWs. Each session lasts between 30 to 45 minutes. The content is delivered through motivational interviewing with additional behavioural and cognitive components. CAP+ will include treatment engagement strategies integrated into CAP. Dependent drinking: Home detoxification will be supervised by a doctor and monitored by the NSHW and a designated carer (e.g. spouse) for the patient at their home-setting. The counselling sessions are delivered by NSHWs, over 4-8 weeks and lasting 30-60 minutes each. |
|
Comparador Ativo: Enhanced usual care
Hazardous drinking: Brief intervention leaflet which is an information sheet/brochure with information on alcohol consumption, associated risks, and tips to manage and reduce drinking. Harmful drinking: CAP is a manualised brief psychological treatment for harmful drinking. It has three phases which are delivered in one to four sessions over six to eight weeks by NSHWs. Each session lasts between 30 to 45 minutes. The content is delivered through motivational interviewing with additional behavioural and cognitive components. CAP has proven to be effective and cost-effective in reducing drinking in men with harmful level of drinking in a prior study. CAP can be delivered in any of the local vernacular (Hindi, Marathi, Konkani) or English. Dependent drinking: Supported in-patient detoxification which is hospital-based detoxification delivered in secondary or tertiary care. |
Hazardous drinking: An information sheet/brochure with information on alcohol consumption, associated risks, and tips to manage and reduce drinking. Harmful drinking: CAP psychological brief treatment delivered by trained NSHWs (described above in detail). Dependent drinking: Hospital-based detoxification delivered in secondary or tertiary care. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage days abstinent (PDA) [Parent trial]
Prazo: 3 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the Timeline Follow Back (TLFB) |
3 months post randomisation
|
|
Pattern of drinking [Sub-group A Hazardous drinking]
Prazo: 3 months post randomisation
|
Number of heavy drinking days in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Treatment completion [Sub-group B Harmful Drinking]
Prazo: Through the period of intervention delivery, an average of 3 months
|
Proportion of consented participants who go on to complete treatment defined as planned discharge which would be one of the following
|
Through the period of intervention delivery, an average of 3 months
|
|
Intensity of drinking [Sub-group C Dependent drinking]
Prazo: 3 months post randomisation
|
Units of alcohol consumed in the past week measured using the TLFB |
3 months post randomisation
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage days abstinent (PDA) [Parent trial]
Prazo: 6 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the Timeline Follow |
6 months post randomisation
|
|
Percentage days abstinent (PDA) [Parent trial]
Prazo: 12 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the Timeline Follow |
12 months post randomisation
|
|
Consequences of alcohol use [Parent trial]
Prazo: 3 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
3 months post randomisation
|
|
Consequences of alcohol use [Parent trial]
Prazo: 6 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
6 months post randomisation
|
|
Consequences of alcohol use [Parent trial]
Prazo: 12 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
12 months post randomisation
|
|
Food security [Parent trial]
Prazo: 12 months post randomisation
|
Improvement of food security as measured using Food Insecurity Experience Scale |
12 months post randomisation
|
|
Pattern of drinking [Parent trial]
Prazo: 3 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Pattern of drinking [Parent trial]
Prazo: 6 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Pattern of drinking [Parent trial]
Prazo: 12 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Intensity of drinking [Parent trial]
Prazo: 3 months post randomisation
|
Grams ethanol consumed per drinking day in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Intensity of drinking [Parent trial]
Prazo: 6 months post randomisation
|
Grams ethanol consumed per drinking day in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Intensity of drinking [Parent trial]
Prazo: 12 months post randomisation
|
Grams ethanol consumed per drinking day in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Remission [Parent trial]
Prazo: 3 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
3 months post randomisation
|
|
Remission [Parent trial]
Prazo: 6 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
6 months post randomisation
|
|
Remission [Parent trial]
Prazo: 12 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
12 months post randomisation
|
|
System-level costs [Parent trial]
Prazo: Monthly, during the period of implementation
|
Economic costs in WHO six building blocks for delivering the interventions measured using inventory form for collecting system-level economic costs of delivering interventions (finance records and individuals involved in delivery of interventions) |
Monthly, during the period of implementation
|
|
Out-of-pocket costs 1 [Parent trial]
Prazo: 3 months post randomisation
|
Out-of-pocket costs for receiving general medical care and the related non-medical costs (e.g.: time loss, travel, etc) measured using Client Service Receipt Inventory form for collecting costs to patients who receive CCAP interventions |
3 months post randomisation
|
|
Out-of-pocket costs 1 [Parent trial]
Prazo: 6 months post randomisation
|
Out-of-pocket costs for receiving general medical care and the related non-medical costs (e.g.: time loss, travel, etc) measured using Client Service Receipt Inventory form for collecting costs to patients who receive CCAP interventions |
6 months post randomisation
|
|
Out-of-pocket costs 1 [Parent trial]
Prazo: 12 months post randomisation
|
Out-of-pocket costs for receiving general medical care and the related non-medical costs (e.g.: time loss, travel, etc) measured using Client Service Receipt Inventory form for collecting costs to patients who receive CCAP interventions |
12 months post randomisation
|
|
Out-of-pocket costs 2 [Parent trial]
Prazo: 3 months post randomisation
|
Out-of-pocket costs for receiving CCAP interventions (e.g.: time loss, travel, etc) using survey form for receiving the CCAP interventions to patients who receive CCAP interventions |
3 months post randomisation
|
|
Out-of-pocket costs 2 [Parent trial]
Prazo: 6 months post randomisation
|
Out-of-pocket costs for receiving CCAP interventions (e.g.: time loss, travel, etc) using survey form for receiving the CCAP interventions to patients who receive CCAP interventions |
6 months post randomisation
|
|
Out-of-pocket costs 2 [Parent trial]
Prazo: 12 months post randomisation
|
Out-of-pocket costs for receiving CCAP interventions (e.g.: time loss, travel, etc) using survey form for receiving the CCAP interventions to patients who receive CCAP interventions |
12 months post randomisation
|
|
Disability [Parent trial]
Prazo: 3 months post randomisation
|
Standardised disability scores used to estimate Quality-Adjusted Life Years (QALYs) using the WHO Disability Assessment Scale (WHODAS) |
3 months post randomisation
|
|
Disability [Parent trial]
Prazo: 6 months post randomisation
|
Standardised disability scores used to estimate Quality-Adjusted Life Years (QALYs) using the WHO Disability Assessment Scale (WHODAS) |
6 months post randomisation
|
|
Disability [Parent trial]
Prazo: 12 months post randomisation
|
Standardised disability scores used to estimate Quality-Adjusted Life Years (QALYs) using the WHO Disability Assessment Scale (WHODAS) |
12 months post randomisation
|
|
Pattern of drinking [Sub-group A Hazardous drinking]
Prazo: 6 months post randomisation
|
Number of heavy drinking days in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Pattern of drinking [Sub-group A Hazardous drinking]
Prazo: 12 months post randomisation
|
Number of heavy drinking days in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Intensity of drinking [Sub-group A Hazardous drinking]
Prazo: 3 months post randomisation
|
Grams ethanol consumed per drinking day in past two weeks measured using the TLFB |
3 months post randomisation
|
|
Intensity of drinking [Sub-group A Hazardous drinking]
Prazo: 6 months post randomisation
|
Grams ethanol consumed per drinking day in past two weeks measured using the TLFB |
6 months post randomisation
|
|
Intensity of drinking [Sub-group A Hazardous drinking]
Prazo: 12 months post randomisation
|
Grams ethanol consumed per drinking day in past two weeks measured using the TLFB |
12 months post randomisation
|
|
Remission [Sub-group A Hazardous drinking]
Prazo: 3 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
3 months post randomisation
|
|
Remission [Sub-group A Hazardous drinking]
Prazo: 6 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
6 months post randomisation
|
|
Remission [Sub-group A Hazardous drinking]
Prazo: 12 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
12 months post randomisation
|
|
Percentage days abstinent (PDA) [Sub-group A Hazardous drinking]
Prazo: 3 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Percentage days abstinent (PDA) [Sub-group A Hazardous drinking]
Prazo: 6 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Percentage days abstinent (PDA) [Sub-group A Hazardous drinking]
Prazo: 12 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Pattern of drinking [Sub-group A Hazardous drinking]
Prazo: 3 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Pattern of drinking [Sub-group A Hazardous drinking]
Prazo: 6 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Pattern of drinking [Sub-group A Hazardous drinking]
Prazo: 12 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Treatment entry [Sub-group B Harmful drinking]
Prazo: 3 months post randomisation
|
Proportion of consented participants who receive at least one session of counselling |
3 months post randomisation
|
|
Treatment entry [Sub-group B Harmful drinking]
Prazo: 6 months post randomisation
|
Proportion of consented participants who receive at least one session of counselling |
6 months post randomisation
|
|
Treatment entry [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Proportion of consented participants who receive at least one session of counselling |
12 months post randomisation
|
|
Percentage days abstinent (PDA) [Sub-group B Harmful drinking]
Prazo: 3 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Percentage days abstinent (PDA) [Sub-group B Harmful drinking]
Prazo: 6 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Percentage days abstinent (PDA) [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Proportion of days abstinent in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Pattern of drinking [Sub-group B Harmful drinking]
Prazo: 3 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
3 months post randomisation
|
|
Pattern of drinking [Sub-group B Harmful drinking]
Prazo: 6 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
6 months post randomisation
|
|
Pattern of drinking [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Percentage days heavy drinking (PDHD) in the past two weeks measured using the TLFB |
12 months post randomisation
|
|
Intensity of drinking [Sub-group B Harmful drinking]
Prazo: 3 months post randomisation
|
Grams ethanol consumed per drinking day in past two weeks measured using the TLFB |
3 months post randomisation
|
|
Intensity of drinking [Sub-group B Harmful drinking]
Prazo: 6 months post randomisation
|
Grams ethanol consumed per drinking day in past two weeks measured using the TLFB |
6 months post randomisation
|
|
Intensity of drinking [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Grams ethanol consumed per drinking day in past two weeks measured using the TLFB |
12 months post randomisation
|
|
Remission [Sub-group B Harmful drinking]
Prazo: 3 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
3 months post randomisation
|
|
Remission [Sub-group B Harmful drinking]
Prazo: 6 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
6 months post randomisation
|
|
Remission [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
12 months post randomisation
|
|
Consequences of alcohol use [Sub-group B Harmful drinking]
Prazo: 3 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
3 months post randomisation
|
|
Consequences of alcohol use [Sub-group B Harmful drinking]
Prazo: 6 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
6 months post randomisation
|
|
Consequences of alcohol use [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
12 months post randomisation
|
|
Food security [Sub-group B Harmful drinking]
Prazo: 12 months post randomisation
|
Improvement of food security as measured using Food Insecurity Experience Scale |
12 months post randomisation
|
|
Intensity of drinking [Sub-group C Dependent drinking]
Prazo: 6 months post randomisation
|
Units of alcohol consumed in the past week measured using TLFB |
6 months post randomisation
|
|
Intensity of drinking [Sub-group C Dependent drinking]
Prazo: 12 months post randomisation
|
Units of alcohol consumed in the past week measured using TLFB |
12 months post randomisation
|
|
Consequences of alcohol use [Sub-group C Dependent drinking]
Prazo: 3 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
3 months post randomisation
|
|
Consequences of alcohol use [Sub-group C Dependent drinking]
Prazo: 6 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
6 months post randomisation
|
|
Consequences of alcohol use [Sub-group C Dependent drinking]
Prazo: 12 months post randomisation
|
Physical, social, intrapersonal and interpersonal consequences of alcohol use measured using the Short Inventory of Problems (SIP) |
12 months post randomisation
|
|
Food security [Sub-group C Dependent drinking]
Prazo: 12 months post randomisation
|
Improvement of food security as measured using Food Insecurity Experience Scale |
12 months post randomisation
|
|
Remission [Sub-group C Dependent drinking]
Prazo: 3 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
3 months post randomisation
|
|
Remission [Sub-group C Dependent drinking]
Prazo: 6 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
6 months post randomisation
|
|
Remission [Sub-group C Dependent drinking]
Prazo: 12 months post randomisation
|
Alcohol Use Disorder Identification Test (AUDIT) score <8 |
12 months post randomisation
|
|
Treatment entry [Sub-group C Dependent drinking]
Prazo: Through the period of intervention delivery, an average of 3 months
|
Proportion of consented participants who receive at least one session of counselling |
Through the period of intervention delivery, an average of 3 months
|
|
Treatment completion [Sub-group C Dependent drinking]
Prazo: Through the period of intervention delivery, an average of 3 months
|
Proportion of consented participants who go on to complete treatment defined as planned discharge which would be one of the following
|
Through the period of intervention delivery, an average of 3 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- AN_2025_119
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .